Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV is Driving Innovation in Healthcare Technology Solutions

Feb 07, 2026

Revolutionizing Healthcare with EvoLV

In the rapidly evolving landscape of healthcare, technology plays a crucial role in enhancing patient care and streamlining operations. EvoLV is at the forefront of this transformation, driving innovation with its cutting-edge healthcare technology solutions. By focusing on patient-centric approaches and integrating advanced technologies, EvoLV is setting new standards for the industry.

healthcare technology

Integrating Artificial Intelligence

Artificial Intelligence (AI) is revolutionizing various sectors, and healthcare is no exception. EvoLV leverages AI to provide predictive analytics, which aids healthcare professionals in making informed decisions. This technology helps in early diagnosis, personalized treatment plans, and efficient resource management. By harnessing the power of AI, EvoLV enhances the accuracy and efficiency of healthcare delivery.

Moreover, AI-driven tools facilitate the automation of routine tasks, allowing medical staff to focus more on patient care. This not only improves productivity but also reduces the risk of human error, ensuring safer patient outcomes.

Enhancing Patient Engagement

Patient engagement is a key factor in successful healthcare outcomes. EvoLV develops solutions that empower patients to take charge of their health. Through user-friendly apps and platforms, patients can easily access their medical records, schedule appointments, and communicate with healthcare providers. This increased accessibility fosters a collaborative environment where patients and providers work together for optimal health management.

patient engagement

By providing real-time updates and reminders, EvoLV helps patients adhere to treatment plans and maintain a proactive approach to their health. This engagement not only improves patient satisfaction but also contributes to better clinical outcomes.

Utilizing Telehealth Solutions

Telehealth has become an essential component of modern healthcare, especially in the wake of the global pandemic. EvoLV offers comprehensive telehealth solutions that ensure patients receive timely care regardless of their location. These solutions include video consultations, remote monitoring, and digital prescriptions, making healthcare more accessible and convenient.

  • Video Consultations: Connect with healthcare professionals from the comfort of your home.
  • Remote Monitoring: Continuous tracking of vital signs for chronic disease management.
  • Digital Prescriptions: Seamless prescription management and refills.
telehealth technology

Data Security and Compliance

In an era where data breaches are a significant concern, EvoLV places a strong emphasis on data security and compliance. The company implements robust encryption protocols and adheres to industry standards such as HIPAA to protect sensitive patient information. This commitment to security ensures that patient data is handled with the utmost care and integrity.

By prioritizing data security, EvoLV builds trust with healthcare providers and patients alike, reinforcing its position as a leader in healthcare technology solutions.

The Future of Healthcare Technology

As technology continues to advance, EvoLV remains dedicated to exploring new possibilities in healthcare innovation. The company actively invests in research and development to introduce next-generation solutions that address emerging challenges. By staying ahead of the curve, EvoLV ensures that healthcare systems are equipped to meet future demands.

With a focus on innovation and patient-centric care, EvoLV is not just keeping pace with the changes in healthcare technology but is actively shaping the future of the industry.